Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy - Wikidata - awgldk - TriplyDB

Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy

Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy

http://www.wikidata.org/entity/Q37073978

about

IRF4 is a key thermogenic transcriptional partner of PGC-1α IRF4 is a novel mediator for neuronal survival in ischaemic stroke Interferon regulatory factor 9 is critical for neointima formation following vascular injury The immune system and hypertension.UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis Dual Activation of TRIF and MyD88 Adaptor Proteins by Angiotensin II Evokes Opposing Effects on Pressure, Cardiac Hypertrophy, and Inflammatory Gene Expression.5-Azacytidine modulates interferon regulatory factor 1 in macrophages to exert a cardioprotective effect Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain TRAF1 is a key mediator for hepatic ischemia/reperfusion injury The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.The potential role of lysosome-associated membrane protein 3 (LAMP3) on cardiac remodelling.Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.Tripartite motif 32 prevents pathological cardiac hypertrophy Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.Interferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin.IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling.Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling Aberrant Epicardial Adipose Tissue Extracellular Matrix Remodeling in Patients with Severe Ischemic Cardiomyopathy: Insight from Comparative Quantitative Proteomics.Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy IRF4 and IRF8: Governing the virtues of B Lymphocytes.Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.Vinexin-β exacerbates cardiac dysfunction post-myocardial infarction via mediating apoptotic and inflammatory responses.Interferon regulatory factor 8 protects against cerebral ischaemic-reperfusion injury.The Histone Methyltransferase Mixed Lineage Leukemia (MLL) 3 May Play a Potential Role on Clinical Dilated Cardiomyopathy Interferon regulatory factors in heart: stress response beyond inflammation.TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease.Functional polymorphism of the renalase gene is associated with cardiac hypertrophy in female patients with aortic stenosis.EZH2 inhibits autophagic cell death of aortic vascular smooth muscle cells to affect aortic dissection.Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.Insights into innate immune signalling in controlling cardiac remodelling.Mechanical stretch induced transcriptomic profiles in cardiac myocytes.Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor.Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction.Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.

P2860

Q28590968-5AC31C7E-57CF-47AC-A665-92929A3AD3ED Q33580173-8F97036F-089B-47B9-A74D-F434A3129393 Q34446578-777983CE-8A2F-4F29-B955-CEAC71D95EDD Q35038155-DBA8E5A1-58E6-4755-A53C-B140711005DE Q35181565-6146B367-1194-467B-B343-C009308FC939 Q35576675-28DBB109-CA69-4B66-BE03-E0574DE41787 Q35846211-09843152-D5E7-4DF2-ABBD-E725147757CC Q35956355-7214261C-534E-494D-8B23-77DA9729FF2E Q36221692-3C3E66D4-D6D9-4EA3-A549-1FA2668398A8 Q36282910-08D9CC5C-458F-4C14-9B63-C22E64DDD4BD Q36291138-F846E40B-C42F-4648-B159-A79367C2FB09 Q36342106-332EC8DF-35EC-4FFE-9551-DCD3980FF0A4 Q36595081-B9AF29FB-7DC4-4F2A-9022-CF4F9D320CF0 Q36714100-78EADBD3-CC1E-4439-B0C6-BD4F8FCEA98C Q36842050-2D243AFB-DD84-4366-9CA9-3CDBC6B58C8E Q36975709-F32FE045-57CF-447E-870B-0747CA139537 Q37546984-2B832F0E-E900-4171-ABE2-5CCD915D89B7 Q37594217-468CC248-D2A7-4BD9-9483-6AB399F6B62B Q37626086-A5911DC7-D25A-4839-B3B3-B8A2DD843D74 Q37678887-CDF1549F-26CA-4B90-8B80-5E0480DCDD39 Q37698309-1C3E9DB9-C064-4F4D-8A07-3272893E7307 Q38288293-76842BD3-773E-4AF2-8491-142F85A67C5A Q38972944-C3341CB5-7B35-4F9A-AC12-1613E54EF4E8 Q39238946-3564B0BA-B2E2-4B8C-8300-643C227A8C9A Q40832729-B47225BF-DE19-4F52-BF4B-F802D04D3878 Q41333298-08C1CB52-BC0C-4135-B479-56F20D414C97 Q41469937-7717ECCC-73FB-4BA4-9617-ACE22509783D Q42237002-1525294B-C262-44FD-8E2F-5DBADED83C82 Q42262138-EB6A0CFE-8A20-4272-B4B2-C7880CDF49E6 Q42637206-A3C31DCF-387B-4296-8571-3CAABF2EDDD3 Q45652001-EF55C259-8DF1-4039-8CAB-06DE5D66866E Q45853761-69FAFC16-DF08-41F1-AC5F-8B1EF3628FE2 Q50130159-03C07454-C245-4437-A775-A7F756F2B187 Q52147501-A7A2DD86-2F5F-4E8C-8098-2C3AD3AAD457 Q52448624-4F331E57-C79F-4442-BFAF-11E63D59D840 Q52651221-8E6737A5-5E28-4386-B229-0A492DE403F3 Q52655959-2D7CE529-0623-40A1-9700-A7EBF78CAC24 Q54168051-1DA20168-0A81-4FF0-AF71-432B9648BA1A Q54385043-08594420-0752-41C4-ACF2-23B209D5A292 Q54403182-C149C03F-B78B-4540-B957-CCFF4D46CFFA

P2860

Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy

http://www.wikidata.org/entity/Q37073978

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of interferon regulatory ...... thological cardiac hypertrophy

@en

Role of interferon regulatory ...... hological cardiac hypertrophy.

@nl

type

label

Role of interferon regulatory ...... thological cardiac hypertrophy

@en

Role of interferon regulatory ...... hological cardiac hypertrophy.

@nl

prefLabel

Role of interferon regulatory ...... thological cardiac hypertrophy

@en

Role of interferon regulatory ...... hological cardiac hypertrophy.

@nl

P1433

Q37073978-690A65DA-3BE1-42B3-B11C-8E4DD2EFAD5B

P1476

Q37073978-4CEFC2FA-6D99-4D9E-B597-70AA62E6230D

P2093

Q37073978-245C055C-6B01-4D31-942C-1B075FD2895B

Q37073978-33FF1C18-A54F-4E04-BCCB-26C465980491

Q37073978-3F2D1933-09AC-4611-BB27-DBBC64CC3130

Q37073978-52C784FC-307D-4787-BC0C-D24E99A4CE6F

Q37073978-7950D462-9E56-40F3-94B1-482F9FB3CA9C

Q37073978-7AF1B560-5D79-402B-9BCD-827BB1F7BD2E

Q37073978-A16BE61D-1195-457A-8480-6D96BECFBCE8

Q37073978-A422BF68-2618-4A31-A3ED-6C88F8349DC6

Q37073978-E598A017-1BB7-42F2-BB3C-8BDEB4A27227

Q37073978-FEF8CBFE-0868-4D87-84B5-C59B35B763DA

P2860

Q37073978-0A0D3EA2-12BA-44F8-8E11-AB400C0CC1CD

Q37073978-2B952EBC-C510-4857-A14C-A4D6FC8515A6

Q37073978-2C458E3E-0D51-4A51-99BD-12286B02FB59

Q37073978-31B2EEE1-021D-4768-B0E2-BB3D7C8AE184

Q37073978-43F8A803-CD64-4D22-8709-A94FB66B3AF9

Q37073978-4DA51E2F-967D-4D63-B7F7-56819525EE35

Q37073978-502C3F4E-5A31-4B5E-BD35-96D527BD5185

Q37073978-56BD5287-6260-4DDE-9CFF-B46B4F590E7C

Q37073978-643BCD66-230A-4ED6-A7D4-5DB5188307E1

Q37073978-6F45C8B2-5A2A-45C4-9EEC-29BC413AE63F

P304

Q37073978-83AF1660-181C-427F-B9FC-FFB99CD86A7E

P31

Q37073978-1CD644BD-6A7F-464C-BED1-3C8781A8682D

P356

Q37073978-470678CB-7147-4122-891D-B3E40413F134

P407

Q37073978-ABCDC520-112C-472D-A1DE-D25E9D71F9DC

P433

Q37073978-00D65D3F-29BC-41AF-A933-374D16011E2D

P478

Q37073978-62FDB975-4787-40AF-AE58-5BF6DEE9BC2B

P50

Q37073978-ABDDBAD5-6E2A-48EA-A58F-E6D87B30B531

P577

Q37073978-2A92564B-C4F0-4F1B-9887-BEA15229A17B

P5875

Q37073978-1C9DD125-C750-4295-A80B-AB9B42B966BE

P698

Q37073978-4EA57844-12CB-43C3-885D-8F8C480F5E43

P932

Q37073978-6DCD82E4-50AA-4FF3-8DB1-39F7F62C2484

P356

HYPERTENSIONAHA.111.00614

P1433

P1476

Role of interferon regulatory ...... thological cardiac hypertrophy

@en

P2093

Ding-Sheng Jiang

http://www.w3.org/2001/XMLSchema#string

Guo-Chang Fan

http://www.w3.org/2001/XMLSchema#string

Hongliang Li

http://www.w3.org/2001/XMLSchema#string

Qinglin Yang

http://www.w3.org/2001/XMLSchema#string

Rui Zhang

http://www.w3.org/2001/XMLSchema#string

Shu-Min Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Dong Zhang

http://www.w3.org/2001/XMLSchema#string

Yan Zhang

http://www.w3.org/2001/XMLSchema#string

Yi Liu

http://www.w3.org/2001/XMLSchema#string

Zhou-Yan Bian

http://www.w3.org/2001/XMLSchema#string

P2860

Transcription factor MITF regulates cardiac growth and hypertrophy

Roles of cardiac transcription factors in cardiac hypertrophy

IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload

Toward transcriptional therapies for the failing heart: chemical screens to modulate genes

Left ventricular hypertrophy: pathogenesis, detection, and prognosis.

IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?

Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload

Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling

Transcriptional control of adipose lipid handling by IRF4

P304

1193-1202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.111.00614

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236186142

http://www.w3.org/2001/XMLSchema#string

P698

23589561

http://www.w3.org/2001/XMLSchema#string

P932

3734933

http://www.w3.org/2001/XMLSchema#string